Financial News · Live Terminal

Page 429 of 546

Stifel Adjusts Price Target on Old Dominion Freight Line to $232 From $228

Old Dominion Freight Line (ODFL) has an average rating of hold and mean price target of $215.77, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $213.27, Change: $+3.92, Percent Change: +1.87%

$ODFL

Wire104d ago

PENN Entertainment Shareholders Urged by UNITE HERE to Back Board Declassification Proposal

PENN Entertainment (PENN) shareholders are being urged by UNITE HERE to vote in favor of a proposal to declassify the company's board of directors at the upcoming annual meeting on June 16, the union said Thursday in a statement.The union said annual elections would support long-term value creation by strengthening confidence in board oversight and enhancing accountability amid industry disruption.PENN's board has recommended shareholders vote against the proposal, according to the statement.PENN didn't immediately reply to a request for comment from.Price: $17.67, Change: $-0.15, Percent Change: -0.84%

$PENN

Wire104d ago

FDA Proposes to Exclude Semaglutide, Tirzepatide, Liraglutide From 503B Bulks List

The US Food and Drug Administration said Thursday it is proposing to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list, finding no clinical need for outsourcing facilities to compound the drugs from bulk substances.Novo Nordisk (NVO) manufactures semaglutide, marketed as Ozempic for type 2 diabetes and Wegovy for chronic weight management, and liraglutide, under the brand name Victoza for type 2 diabetes and Saxenda for chronic weight management. Eli Lilly (LLY) manufactures tirzepatide, marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management.Normally, outsourcing facilities cannot compound drugs using bulk drug substances unless the substance is on the 503B bulks list or the compounded drug is on the FDA's drug shortage list at the time of compounding, distribution, and dispensing, the FDA said.Novo Nordisk and Eli Lilly didn't immediately reply to requests for comment from.Price: $42.48, Change: $+2.19, Percent Change: +5.44%

$LLY$NVO

Wire104d ago

KBR Makes Strategic Investment in Geolith

KBR (KBR) said Thursday that it has made a strategic investment in Geolith, a France-based direct lithium extraction company.Financial terms of the investment were not disclosed.The investment will support the global commercial deployment of Geolith's Direct Lithium Extraction Li-Capt technology, KBR said.KBR shares were up 2.3% in Thursday trading.Price: $36.99, Change: $+0.97, Percent Change: +2.69%

$KBR

Wire104d ago

Red Cat Wins Contract to Deliver 173 Black Widow Drone Systems to Japan

Red Cat (RCAT) has won a contract to deliver 173 of its Black Widow small unmanned aircraft systems from the Acquisition, Technology & Logistics Agency, an external bureau of Japan's Ministry of Defense, the company said Thursday.Financial terms of the contract were not disclosed.The company said that a concurrent contract will cover spare parts and training for the systems.Price: $11.45, Change: $+0.38, Percent Change: +3.43%

$RCAT

Wire104d ago

Starboard Urges Lamb Weston Board to Host Investor Day, Reset Earnings

Lamb Weston (LW) shareholder Starboard Value said in a letter to the board Thursday that the company should hold an investor day and reset earnings to a normalized level.Starboard said an investor day would allow the company to highlight its core strengths, reaffirm its competitive advantages, and focus on key priorities. The company must also present a clear plan to restore earnings and deliver long-term growth, Starboard said.The first step is to bring earnings to a normalized level, Starboard said, adding that it believes the company can reach a 25% adjusted earnings before interest, taxes, depreciation, and amortization margin by fiscal 2029 through a mix of profitable revenue growth and cost reductions.However, restoring earnings is not enough; the company must also show it can grow consistently over the long term, Starboard added. "Management needs to earn back the trust that they have lost and convince shareholders that the team understands how to maintain a high-quality business and create value," the firm said.Lamb Weston didn't immediately reply to' request for comment.Price: $43.52, Change: $+0.48, Percent Change: +1.13%

$LW

Wire104d ago

Barclays Adjusts Price Target on Old Dominion Freight Line to $210 From $185

$ODFL

Wire104d ago

Solstice Advanced Materials JV ConverDyn Signs Uranium Conversion Deal with Hadron Energy

Solstice Advanced Materials (SOLS) joint venture ConverDyn has signed a uranium conversion services agreement with Hadron Energy, the latter said Thursday.Under the agreement, ConverDyn will supply uranium hexafluoride to support Hadron's fuel fabrication pathway, with the collaboration spanning the full commercialization of Hadron's Halo microreactor commercial roadmap, Hadron said.Hadron said previously that it is set to merge with GigCapital7 (GIG), subject to approval at shareholder meeting scheduled for May 7.Solstice shares were up 3% in Thursday's trading.Price: $79.32, Change: $+2.36, Percent Change: +3.06%

$GIG$SOLS

Wire104d ago

Teleflex Names Jason Weidman as President, CEO

Teleflex (TFX) said Thursday it has appointed Jason Weidman as president and chief executive officer, starting June 8.Weidman will succeed interim CEO Stuart Randle, who will remain on the company's board of directors, it added.Shares of Teleflex were down nearly 6% in Thursday trading.Price: $125.69, Change: $-7.61, Percent Change: -5.71%

$TFX

Wire104d ago

AVITA Medical Names Cary Vance as CEO

AVITA Medical's (RCEL) board appointed Cary Vance as president and chief executive officer, effective immediately after serving as CEO on an interim basis since October, the company said Thursday.The board also named Jan Stern Reed as chairman, with immediate effect, AVITA Medical said.Price: $4.33, Change: $+0.10, Percent Change: +2.36%

$RCEL

Wire104d ago

NLIGHT Plans to Expand Operations in Torino, Italy

NLIGHT (LASR) said Thursday it plans to expand its existing facility in Torino, Italy, to meet growing demand for locally assembled directed energy systems.The company said the expansion will enhance its capability to supply high-power laser subsystems and integrated components tailored to regional requirements.The upgraded site will focus on local assembly, testing, and lifecycle support for defense applications in European and Middle Eastern markets, nLIGHT said.Shares of the company were up 3.4% in Thursday trading.Price: $67.15, Change: $+2.18, Percent Change: +3.36%

$LASR

Wire104d ago

DoorDash, Lyft Expand Partnership Into Canada

DoorDash (DASH) and Lyft (LYFT) said Thursday they are expanding their partnership into Canada, enhancing the value of DashPass by introducing rideshare savings for members.DashPass is DoorDash's membership program designed to help customers save on everyday purchases, offering free delivery and reduced service fees on eligible orders.The expansion aims to transform DashPass into a broader lifestyle membership and help Lyft reach a new rider base, according to the statement.DashPass members can save on Lyft through upfront discounts on eligible rides, the statement added.Price: $169.50, Change: $+0.16, Percent Change: +0.10%

$DASH$LYFT

Wire104d ago

B. Riley Downgrades Etsy to Neutral From Buy, Lifts Price Target to $75 From $70

Etsy (ETSY) has an average rating of Hold and mean price target of $71.79, according to analysts polled by FactSet.Price: $64.59, Change: $-5.01, Percent Change: -7.20%

$ETSY

Wire104d ago

B. Riley Adjusts Core Natural Resources PT to $116 From $119, Maintains Buy Rating

$CNR

Wire104d ago

Oppenheimer Adjusts Price Target on Ionis Pharmaceuticals to $110 From $104, Maintains Outperform Rating

Ionis Pharmaceuticals (IONS) has an average rating of overweight and mean price target of $105.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $75.25, Change: $+0.42, Percent Change: +0.55%

$IONS

Wire104d ago

Oppenheimer Adjusts Price Target on Lennox International to $650 From $645, Maintains Outperform Rating

Lennox International (LII) has an average rating of hold and mean price target of $559.75, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $545.33, Change: $+27.71, Percent Change: +5.35%

$LII

Wire104d ago

Oppenheimer Adjusts Price Target on KLA to $2,000 From $1,900, Maintains Outperform Rating

KLA (KLAC) has an average rating of overweight and mean price target of $1,860, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $1720.67, Change: $-95.55, Percent Change: -5.26%

$KLAC

Wire104d ago

Eos Energy Enterprises Names Alessandro Lagi as CFO

Eos Energy Enterprises (EOSE) said Thursday it appointed Alessandro Lagi as chief financial officer, effective June 8, 2026.Lagi is joining the company from Johnson Controls (JCI), where he most recently led the Global FP&A and Growth finance team, Eos said.Eos shares were up 2.3% in Thursday morning trading.Price: $6.44, Change: $+0.10, Percent Change: +1.59%

$EOSE

Wire104d ago

Update: Caterpillar Shares Rise After Q1 Beat, Higher 2026 Guidance

(Updates with the latest stock movement in the headline and the first paragraph, and 2026 guidance details in the last paragraph.Caterpillar (CAT) shares rose 9.6% in Thursday trading after the company posted better-than-expected Q1 results and raised its 2026 revenue guidance.The company reported Q1 adjusted profit of $5.54 per share, up from $4.25 a year earlier.Analysts polled by FactSet expected $4.65.Total sales and revenue for the quarter ended March 31 were $17.42 billion, compared with $14.25 billion a year earlier.Analysts polled by FactSet expected $16.53 billion.Chief Executive Joseph Creed said during the earnings call that the company raised its outlook and now expects low double-digit growth for full-year 2026 sales and revenue, citing solid execution and resilient markets.Price: $887.52, Change: $+77.47, Percent Change: +9.56%

$CAT

Wire104d ago

Update: Mastercard Shares Fall After April Cross-Border Volumes Grow at Slower Pace, Q1 Results

(Updates with the latest stock move and in the headline and in the first paragraph, details on April-to-date data in the second paragraph.)Mastercard (MA) shares were down 3.5% in Thursday trading after the company posted a slowdown in April month-to-date cross-border volumes growth, even as it reported better than expected Q1 results.The company recorded April month-to-date cross-border volumes growth of 9% compared to 12% in March and 13% for the Q1. Meanwhile, April switched volume growth was 8% versus 9% in March and switched transactions growth were 9%, unchanged from the previous month.Additionally, Mastercard reported Q1 adjusted earnings of $4.60 per diluted share, up from $3.73 a year earlier.Analysts polled by FactSet expected $4.41.Net revenue for the quarter ended March 31 was $8.40 billion, up from $7.25 billion a year earlier.Analysts polled by FactSet expected $8.26 billion.Price: $508.00, Change: $-17.23, Percent Change: -3.28%

$MA

Showing 8561-8580 of 10918